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Abstract
We propose a new statistics for the detection of differentially expressed
genes, when the genes are activated only in a subset of the samples. Statis-
tics designed for this unconventional circumstance has proved to be valu-
able for most cancer studies, where oncogenes are activated for a small
number of disease samples. Previous efforts made in this direction include
COPA ([Tomlins and others(2005)]), OS ([Tibshirani and Hastie(2006)])
and ORT ([Wu(2007)]). We propose a new statistics called maximum or-
dered subset t-statistics (MOST) which seems to be natural when the
number of activated samples is unknown. We compare MOST to other
statistics and find the proposed method often has more power then its
competitors. Cancer; COPA; Differential gene expression; Microarray.
1 Introduction
The most popular method for differential gene expression detection in two-
sample microarray studies is to compute the t-statistics. The differentially ex-
pressed genes are those whose t-statistics exceed a certain threshold. Recently,
due to the realization that in many cancer studies, many genes show increased
expressions in disease samples, but only for a small number of those samples.
The study of [Tomlins and others(2005)] shows that t-statistics has low power
in this case, and they introduced the so-called “cancer outlier profile analysis”
(COPA). Their study shows clearly that COPA can perform better than the
traditional t-statistics for cancer microarray data sets.
More recently, several progresses have been made in this direction with the
aim to design better statistics to account for the heterogeneous activation pat-
tern of the cancer genes. In [Tibshirani and Hastie(2006)], the authors intro-
duced a new statistics, which they called outlier sum. Later, [Wu(2007)] pro-
posed outlier robust t-statistics (ORT) and showed it usually outperformed the
previously proposed ones in both simulation study and application to real data
set.
In this paper, we propose another statistics for the detection of cancer dif-
ferential gene expression which have similar power to ORT when the number of
activated samples are very small, but perform betters when more samples are
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differentially expressed. We call our new method the maximum ordered subset
t-statistics (MOST). Through simulation studies we found the new statistics
outperformed the previously proposed ones under some circumstances and never
significantly worse in all situations. Thus we think it is a valuable addition to
the dictionary of cancer outlier expression detection.
2 Maximum ordered subset t-statistics (MOST)
We consider the simple 2-class microarray data for detecting cancer genes. We
assume there are n normal samples and m cancer samples. The gene expressions
for normal samples are denoted by xij for genes i = 1, 2, . . . , p and samples j =
1, 2, . . . n, while yij denote the expressions for cancer samples with i = 1, 2, . . . , p
and j = 1, 2, . . .m. In this paper, we are only interested in one-sided test where
the activated genes from cancer samples have a higher expression level. The
extension to two-sided test is straightforward.
The usual t-statistics (up to a multiplication factor independent of genes)
for two-sample test of differences in means is defined for each gene i by
Ti =
x¯i − y¯i
si
, (1)
where x¯i =
∑
j xij/n is the average expression of gene i in normal samples,
y¯i =
∑
j yij/m is the average expression of gene i in cancer samples, and si is
the usual pooled standard deviation estimate
s2i =
∑
1≤j≤n(xij − x¯i)
2 +
∑
1≤j≤m(yij − y¯i)
2
n+m− 2
.
The t-statistics is powerful when the alternative distribution is such that yij , j =
1, 2, . . . ,m all come from a distribution with a higher mean. [Tomlins and others(2005)]
argues that for most cancer types, heterogeneous activation patterns make t-
statistics inefficient for detecting those expression profiles. They defined the
COPA statistics
Ci =
qr({yij}1≤j≤m)−medi
madi
, (2)
where qr(·) is the rth percentile of the data,medi = median({xij}1≤j≤n, {yij}1≤j≤m)
is the median of the pooled samples for gene i, andmadi = 1.4826×median({xij−
medi}1≤j≤n, {yij−medi}1≤j≤m) is the median absolute deviation of the pooled
samples.
The choice of r in (2) depends on the subjective judgement of the user. The
use of medi and madi to replace the mean and the standard deviation in (1)
is due to robustness considerations since it is already known that some of the
genes are differentially expressed.
In (2), only one value of {yij} is used in the computation. A more efficient
strategy would be to use additional expression values. Let
Oi = {yij : yij > q75({xij}1≤j≤n, {yij}1≤j≤m)+ IQR({xij}1≤j≤n, {yij}1≤j≤m)}
(3)
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be the outliers from the cancer samples for gene i, where IQR(·) is the interquar-
tile range of the data. The OS statistics from [Tibshirani and Hastie(2006)] is
then defined as
OSi =
∑
yij∈Oi
(yij −medi)
madi
. (4)
More recently, [Wu(2007)] studied ORT statistics, which is similar to OS statis-
tics. The important difference that makes ORT superior is that outliers are
defined relative to the normal sample instead of the pooled sample. So in their
definition,
Oi = {yij : yij > q75({xij}1≤j≤n) + IQR({xij}1≤j≤n)} (5)
By similar reasoningmedi in OS is replaced bymedix andmadj bymedian({xij−
medix}1≤j≤n, {yij −mediy}1≤j≤m), where medix and mediy are the medians of
normal and cancer samples respectively.
In both OS and ORT statistics, the outliers are defined somewhat arbitrarily
with no convincing reasons. To address this question, we propose the following
statistics that implicitly considers all possible values for outlier thresholds.
Suppose for notational simplicity that {yij}1≤j≤m are ordered for each i:
yi1 ≥ yi2 ≥ · · · ≥ yim.
If the number of samples where oncogenes are activated were known, we would
naturally define the statistics as
Mik =
∑
1≤j≤k(yij −medix)
median({xij −medix}1≤j≤n, {yij −mediy}1≤j≤m)
. (6)
When k is not known to us, one would be tempted to define
Mi = max
1≤k≤m
Mik.
But this does not quite work since obviously Mik for different values of k are
not directly comparable under the null distribution that xij , yij ∼ N(0, 1). For
example, when m = 2, we have E[yi1 − medix] > 0 while E[
∑
j=1,2(yij −
medix)] = 0. This observation motivates us to normalize Mik such that each
approximately has mean 0 and variance 1. This can be achieved by defining
µk = E[
∑
1≤j≤k zj ] and σ
2
k = V ar(
∑
1≤j≤k zj) where z1 > z2 > · · · > zm is the
order statistics of m samples generated from the standard normal distribution.
Then we can define Mik as:
Mik =
( ∑
1≤j≤k(yij −medix)
1.4826×median({xij −medix}1≤j≤n, {yij −mediy}1≤j≤m)
− µk
)
/σk,
(7)
so that Mik has mean and variance approximately equal to 0 and 1 respectively.
Finally we can define our new statistics (called MOST) as
Mi = max
1≤k≤m
Mik. (8)
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With MOST, we practically consider every possible threshold above which yij
are taken to be outliers. In this formulation, the number of outliers is implicitly
defined as
arg max
1≤k≤m
Mik. (9)
3 Simulation studies and application
Some simulations are carried out to study MOST, and compare its performance
to OS, ORT, COPA, and t-statistics. For COPA, we choose to use the 90th
percentile in its definition as in [Tibshirani and Hastie(2006)]. We generate the
expression data from standard normal with n = m = 20. For various values
k, 1 ≤ k ≤ m, which is the number of differentially expressed cancer samples,
a constant µ is added for differentially expressed genes. We simulated 1000
differentially and non-differentially expressed genes, and calculated the ROC
curves from them by choosing different thresholds for gene calls.
Figure 1 and 2 plots the ROC curves for some combinations of k and µ. For
µ = 2 and k small, all five statistics behave similarly with t-statistics performing
the worst. As k increases, t becomes better and OS and COPA begin to lose
power. For µ = 1 and medium to large k, the performance of MOST is only
worse than t and better than other statistics. Smaller k in this case basically
leads to ROC curve that is close to a 45o line for all statistics since the signal
µ = 1 is too weak in this case, so we do not show these results. For µ = 4
and small k, MOST is better than ORT, COPA and t, and in this situation
only OS is competitive with MOST. Larger k in this case will produce nearly
perfect ROC curves for all statistics, and thus those results are also omitted.
Besides ROC curves, we have also tried examining the possibility of using (9)
for estimating the number of differentially expressed samples k, but so far have
been unable to get a reasonable estimate out of it.
From the above simulations, we judge that our new estimate MOST is at
least as good as other previously proposed statistics, sometimes much better.
Thus it is a valuable tool for detecting activated genes in many situations.
As an example of real data application, the data from [West and others(2001)]
is publicly available from http://data.cgt.duke.edu/west.php. The microarray
used in the breast cancer study contains 7129 genes and 49 tumor samples,
25 of which with no positive lymph nodes identified and the other 24 with
positive nodes. Similar to [Wu(2007)], we take the log transformation of the
expressions after normalizing the data. We apply MOST to the data and com-
pare it to the t-statistics by computing the FDR using the SAM approach
([Tusher and others(2001)]). Figure 3 plots the FDR versus the number of genes
called significant. For this example, MOST seems to perform a little better than
t-statistics, although the difference is too small to be of any significance.
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Figure 1: ROC curves estimated based on simulation. The number of nor-
mal/cancer sample is n = m = 20. Various combinations of µ and k’s are
chosen. Other uninteresting results where all statistics have close to perfectly
good or bad performances are excluded as explained in the main text.
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Figure 2: More ROC curves.
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Figure 3: FDR versus the number of genes called significant.
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